Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs
- PMID: 20696039
- PMCID: PMC2924856
- DOI: 10.1186/1471-2180-10-212
Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs
Abstract
Background: Epitope vaccines have been suggested as a strategy to counteract viral escape and development of drug resistance. Multiple studies have shown that Cytotoxic T-Lymphocyte (CTL) and T-Helper (Th) epitopes can generate strong immune responses in Human Immunodeficiency Virus (HIV-1). However, not much is known about the relationship among different types of HIV epitopes, particularly those epitopes that can be considered potential candidates for inclusion in the multi-epitope vaccines.
Results: In this study we used association rule mining to examine relationship between different types of epitopes (CTL, Th and antibody epitopes) from nine protein-coding HIV-1 genes to identify strong associations as potent multi-epitope vaccine candidates. Our results revealed 137 association rules that were consistently present in the majority of reference and non-reference HIV-1 genomes and included epitopes of two different types (CTL and Th) from three different genes (Gag, Pol and Nef). These rules involved 14 non-overlapping epitope regions that frequently co-occurred despite high mutation and recombination rates, including in genomes of circulating recombinant forms. These epitope regions were also highly conserved at both the amino acid and nucleotide levels indicating strong purifying selection driven by functional and/or structural constraints and hence, the diminished likelihood of successful escape mutations.
Conclusions: Our results provide a comprehensive systematic survey of CTL, Th and Ab epitopes that are both highly conserved and co-occur together among all subtypes of HIV-1, including circulating recombinant forms. Several co-occurring epitope combinations were identified as potent candidates for inclusion in multi-epitope vaccines, including epitopes that are immuno-responsive to different arms of the host immune machinery and can enable stronger and more efficient immune responses, similar to responses achieved with adjuvant therapies. Signature of strong purifying selection acting at the nucleotide level of the associated epitopes indicates that these regions are functionally critical, although the exact reasons behind such sequence conservation remain to be elucidated.
Figures


Similar articles
-
Discovery of novel targets for multi-epitope vaccines: screening of HIV-1 genomes using association rule mining.Retrovirology. 2009 Jul 6;6:62. doi: 10.1186/1742-4690-6-62. Retrovirology. 2009. PMID: 19580659 Free PMC article.
-
Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.J Virol. 2004 Feb;78(3):1324-32. doi: 10.1128/jvi.78.3.1324-1332.2004. J Virol. 2004. PMID: 14722287 Free PMC article.
-
Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.J Virol. 2002 Sep;76(17):8757-68. doi: 10.1128/jvi.76.17.8757-8768.2002. J Virol. 2002. PMID: 12163596 Free PMC article.
-
Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. doi: 10.1089/08892220050140982. AIDS Res Hum Retroviruses. 2000. PMID: 11018863 Review.
-
The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.J Infect Dis. 2021 Feb 15;223(12 Suppl 2):32-37. doi: 10.1093/infdis/jiaa333. J Infect Dis. 2021. PMID: 33586771 Free PMC article. Review.
Cited by
-
Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?Ther Adv Vaccines Immunother. 2019 Oct 3;7:2515135519874677. doi: 10.1177/2515135519874677. eCollection 2019. Ther Adv Vaccines Immunother. 2019. PMID: 31620673 Free PMC article.
-
Protective immunity against Trichinella spiralis infection induced by a multi-epitope vaccine in a murine model.PLoS One. 2013 Oct 10;8(10):e77238. doi: 10.1371/journal.pone.0077238. eCollection 2013. PLoS One. 2013. PMID: 24130862 Free PMC article.
-
Immune activation promotes evolutionary conservation of T-cell epitopes in HIV-1.PLoS Biol. 2013;11(4):e1001523. doi: 10.1371/journal.pbio.1001523. Epub 2013 Apr 2. PLoS Biol. 2013. PMID: 23565057 Free PMC article.
-
Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.Mol Ther. 2016 Sep;24(9):1686-96. doi: 10.1038/mt.2016.122. Epub 2016 Jun 20. Mol Ther. 2016. PMID: 27434590 Free PMC article.
-
Recognition of higher order patterns in proteins: immunologic kernels.PLoS One. 2013 Jul 29;8(7):e70115. doi: 10.1371/journal.pone.0070115. Print 2013. PLoS One. 2013. PMID: 23922927 Free PMC article.
References
-
- Florescu D, Kotler DP. Insulin resistance, glucose intolerance and diabetes mellitus in HIV-infected patients. Antivir Ther. 2007;12(2):149–162. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical